Zdrowie i gospodarka · 11/06/2026

FDA Classifies Spinal Muscular Atrophy Newborn Screening Test System into Class II Special Controls

The FDA is classifying the Spinal Muscular Atrophy newborn screening test system into Class II, special controls, to ensure safety and effectiveness, and to reduce regulatory burdens, ultimately enhancing patients' access to innovative devices.